Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Aescuvest is a venture capital boutique founded in 2015 in Frankfurt, Germany. The firm focuses on health technology (healthtech) investments, aiming to address real-world medical challenges through strategic investments in innovative startups. Aescuvest has established itself as a key player in the healthtech sector, with a portfolio that includes 13 companies.
The firm operates primarily in Europe and the Middle East, leveraging its expertise to identify and support promising healthtech startups. Aescuvest has a rigorous selection process that evaluates potential investments based on their ability to tackle significant medical issues. The firm has achieved notable milestones, including successful exits such as Piur Imaging, which was acquired in 2022.
Currently, Aescuvest manages a diverse portfolio and continues to seek out new investment opportunities in the healthtech space. The firm is committed to advancing healthcare technology through its investments and partnerships.
Aescuvest invests in healthtech startups that focus on various sectors, including remote monitoring, detection and diagnosis, personalized medicine, and artificial intelligence in healthcare. The firm primarily targets early-stage companies, typically in the seed to Series A range, with check sizes that align with the needs of these startups.
Geographically, Aescuvest operates in Europe and the Middle East, allowing it to tap into a wide array of healthtech innovations. The firm emphasizes a rigorous selection process to identify startups that demonstrate strong potential for growth and impact in the healthcare sector. Aescuvest looks for founders who are not only innovative but also possess a deep understanding of the medical challenges they aim to address.
In addition to financial support, Aescuvest seeks to provide strategic guidance and resources to its portfolio companies, enhancing their chances of success in a competitive market.
Aescuvest's portfolio consists of 13 healthtech startups, each contributing to the advancement of healthcare technology. Notable companies include:
This diverse portfolio highlights Aescuvest's commitment to investing in innovative solutions that address critical healthcare needs.
Key team members at Aescuvest include:
To pitch Aescuvest, startups should submit their proposals through the firm's website at [aescuvest.vc](https://aescuvest.vc). The pitch deck should include a clear overview of the business model, market opportunity, and team qualifications.
Founders should expect a response time of approximately 2-4 weeks after submission. Aescuvest prefers warm introductions but will also consider direct applications through their website.
In 2022, Aescuvest achieved a notable exit with the acquisition of Piur Imaging, marking a significant milestone for the firm. This exit underscores Aescuvest's ability to identify and support promising healthtech startups.
As of 2023, Aescuvest continues to expand its portfolio, actively seeking new investment opportunities in the healthtech sector across Europe and the Middle East. The firm remains committed to advancing healthcare technology through its investments.
What are Aescuvest's investment criteria?
Aescuvest focuses on healthtech startups that address real-world medical challenges. The firm looks for companies involved in remote monitoring, personalized medicine, and AI in healthcare.
How can startups apply or pitch to Aescuvest?
Startups can pitch to Aescuvest through their website at [aescuvest.vc](https://aescuvest.vc). The firm prefers detailed decks that outline the startup's vision, market potential, and team background.
What makes Aescuvest different from other venture capital firms?
Aescuvest specializes exclusively in healthtech investments, allowing them to leverage deep industry knowledge and a rigorous selection process to identify promising startups.
What is Aescuvest's geographic scope?
The firm primarily operates in Europe and the Middle East, focusing on healthtech innovations emerging from these regions.
What is Aescuvest's approach to post-investment involvement?
Aescuvest provides operational support and strategic guidance to its portfolio companies, helping them navigate challenges and scale effectively.
What is the typical fund size and check size for Aescuvest?
Aescuvest typically invests in early-stage companies with check sizes that align with the needs of startups in the seed to Series A range.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.